Dynavax Technologies Corporation (DVAX)

Operating return on assets (Operating ROA)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Operating income (ttm)	US$ in thousands	-2,070	-8,929	-13,895	-23,360	-24,715	46,911	103,192	234,824	283,522	301,104	255,775	136,720	134,486	41,874	11,981	-20,530	-68,371	-83,865	-100,669	-116,301
Total assets	US$ in thousands	986,256	1,061,990	1,016,320	986,565	997,096	972,933	936,432	969,922	985,850	999,337	1,023,000	1,008,980	1,039,250	919,711	647,909	490,119	353,272	353,395	329,314	259,256
Operating ROA		-0.21%	-0.84%	-1.37%	-2.37%	-2.48%	4.82%	11.02%	24.21%	28.76%	30.13%	25.00%	13.55%	12.94%	4.55%	1.85%	-4.19%	-19.35%	-23.73%	-30.57%	-44.86%

December 31, 2024 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $-2,070K ÷ $986,256K
= -0.21%

Dynavax Technologies Corporation's operating return on assets (ROA) has shown a fluctuating trend over the periods presented. The company experienced negative operating ROA figures in the early periods, indicating that its operating income generated from its assets was insufficient to cover the asset base, leading to operational inefficiencies and potential challenges in asset utilization.

However, there was a noticeable improvement in the operating ROA figures starting from March 31, 2022, where the company began to generate positive returns on its assets. This positive trend continued to strengthen, peaking at 30.13% on September 30, 2022, indicating that Dynavax was effectively utilizing its operating assets to generate profits.

Subsequently, there was a slight decrease in the operating ROA figures in the following periods, but overall remained positive until December 31, 2024. The declining trend in the last few periods could suggest potential challenges in maintaining or further enhancing operational efficiency and asset utilization, requiring ongoing monitoring and strategic adjustments to optimize returns on assets.

Overall, the positive turn in Dynavax Technologies Corporation's operating ROA demonstrates an improved operational performance and a more effective utilization of its assets to generate income, albeit with some fluctuations in the later periods.